InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
29
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Hykes Andrew, Chief Executive Officer and President. Director active across 2 companies, notably Inari Medical, Inc.. Cumulatively, 54 filings have been published. Breakdown: 0 buy · 29 sells. Total volume traded: €6.8m. Activity tracked since 19 May 2021. The latest transaction was disclosed on 10 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hykes Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations54 total
5,046 sharesCommon StockSEC:0001806431-26-000004:0
1,550 sharesCommon StockSEC:0001127602-25-005734:0
161,100 shares@ US$0.42840.8% of flowCommon StockSEC:0001127602-25-004391:0
67,282 shares0Common StockSEC:0001127602-25-003433:0
509 shares@ US$51.050.3% of flowCommon StockSEC:0001127602-25-000485:0
2,400 shares@ US$55.201.4% of flowCommon StockSEC:0001127602-24-029927:0
3,000 shares@ US$50.831.6% of flowCommon StockSEC:0001127602-24-027912:0
3,000 shares@ US$50.001.6% of flowCommon StockSEC:0001127602-24-026168:0
508 shares@ US$40.630.2% of flowCommon StockSEC:0001127602-24-025128:0
3,000 shares@ US$50.001.5% of flowCommon StockSEC:0001127602-24-022796:0
3,000 shares@ US$55.231.7% of flowCommon StockSEC:0001127602-24-020966:0
3,000 shares@ US$50.081.6% of flowCommon StockSEC:0001127602-24-020038:0
3,000 shares@ US$50.001.6% of flowCommon StockSEC:0001127602-24-017012:0
508 shares0Common StockSEC:0001127602-24-012247:0
40,786 shares0Common StockSEC:0001127602-24-006227:0
508 shares@ US$64.920.3% of flowCommon StockSEC:0001127602-24-000288:0
21,033 shares@ US$59.5313.1% of flowCommon StockSEC:0001127602-23-027915:0
497 shares@ US$65.400.3% of flowCommon StockSEC:0001127602-23-025402:0
18,166 shares@ US$65.3112.4% of flowCommon StockSEC:0001127602-23-022961:0
347 shares@ US$58.140.2% of flowCommon StockSEC:0001127602-23-020265:0
818 shares@ US$70.870.6% of flowCommon StockSEC:0001127602-23-016225:0
347 shares@ US$61.740.2% of flowCommon StockSEC:0001127602-23-012450:0
7,200 shares@ US$64.184.9% of flowCommon StockSEC:0001127602-23-010958:0
430,517 shares0Common StockSEC:0001127602-23-010147:0
46,549 shares0Common StockSEC:0001127602-23-006508:0
25 of 54 declarations
About Hykes Andrew
Hykes Andrew is Chief Executive Officer and President, and a Director at SHOULDER INNOVATIONS, INC. He has 54 filings in total, and in the sampled recent filings all transactions are sales, for a total of EUR 6846538, covering the period from 2021-05-20 to 2026-06-29. The main recent filings concern Inari Medical, Inc., with amounts of EUR 1153517.046330208 on 2023-11-17, EUR 1090973.886225625 on 2023-08-18, EUR 493453.2930554347 on 2021-09-17, EUR 432720.5418361737 on 2023-03-21, EUR 428623.8076723501 on 2021-08-19, and EUR 375719.5467224543 on 2022-11-22.
